glp 1 meds and alcohol consumption GLP-1 receptor agonists may protect the liver during 𝗢𝗻𝗲 𝗼𝗳 𝘁𝗵𝗲 𝗺𝗼𝘀𝘁 𝘂𝗻𝗲𝘅𝗽𝗲𝗰𝘁𝗲𝗱

A recent study shows people with obesity taking GLP-1 drugs are 20% less likely to suffer a cardiovascular event, and studies are under way for their use to treat the liver disease non-alcoholic steatohepatitis, as well as the neurodegenerative conditions Parkinsons and Alzheimers

MT from wild populations of the African Catfish Clarias gariepinus : from sequence, protein expression and metal binding properties to transcriptional biomarker of metal pollution

Brightens and refreshes skin

Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction

Finerenone, a novel selective nonsteroidal mineralocorticoid receptor antagonist protects from rat cardiorenal injury

Slight nausea after eating too quickly